Clinical development of the histone deacetylase inhibitor suberoylanalide hydroxamic acid (SAHA) in aggressive non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD) Meeting Abstract


Authors: O'Connor, O. A.; Kelly, W.; Wang, E. S.; Richon, V.; Moskowitz, C.; Tong, W.; Donnelly, G.; Zelenetz, A. D.; Moore, M. A. S.; Rifkind, R. A.; Marks, P. A.
Abstract Title: Clinical development of the histone deacetylase inhibitor suberoylanalide hydroxamic acid (SAHA) in aggressive non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD)
Meeting Title: 43rd Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 98
Issue: 11 Pt. 1
Meeting Dates: 2001 Dec 7-11
Meeting Location: Orlando, FL
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2001-11-16
Start Page: 611a
Language: English
ACCESSION: WOS:000172134102569
PROVIDER: wos
PUBMED: 11727739
Notes: Meeting Abstract: 2562 -- Source: Wos
MSK Authors
  1. Victoria M Richon
    82 Richon
  2. William Ping-Yiu Tong
    130 Tong
  3. Craig Moskowitz
    375 Moskowitz
  4. William K Kelly
    110 Kelly
  5. Eunice S Wang
    13 Wang
  6. Andrew D Zelenetz
    556 Zelenetz
  7. Malcolm A S Moore
    427 Moore
  8. Paul Marks
    143 Marks
  9. Richard Rifkind
    75 Rifkind
Related MSK Work